Clinical Trial

Study of NM8074 in Patients With aHUS With Evidence of Ongoing Thrombotic Microangiopathy

Name: Study of NM8074 in Patients With aHUS With Evidence of Ongoing Thrombotic Microangiopathy — clinical trial record (NCT05684159)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Not Yet Recruiting Phase 2

View on ClinicalTrials.gov →

Summary

This is a Phase II, open-label study designed to determine if intravenously administered NM8074 results in remission from TMA in treatment-naïve aHUS patients.

Protocol Amendment History 4 amendments

This ClinicalTrials.gov record has been amended 4 times since 2023-01-12; most recent amendment 2026-04-07.

Trial Details

NCT Number	NCT05684159
Lead Sponsor	NovelMed Therapeutics
Conditions	aHUS - Atypical Hemolytic Uremic Syndrome
Enrollment	12 participants
Start Date	2027-11
Primary Completion	2030-04 (estimated)
Study Completion	2031-02 (estimated)
Updated on ClinicalTrials.gov	2026-04-13